Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago

June 17, 2011

Almac, a leading provider of clinical supply and IXRS® (IVRS/IWRS) technology solutions, announced today that it will showcase new enhancements to its suite of Integrated Supply Chain Management and Patient Compliance Services at the 47th Annual DIA Meeting in Chicago, IL. The new services (Shipping Temperature Electronic Monitoring System (STEMS), SMS/Text patient reminders, and consultation on packaging and labeling designs to improve patient compliance) are designed to support Almac’s objective of Making Clinical Trials Work BetterTM for patients, sites, and sponsors.

STEMS is a web-enabled, fully-validated data management system that assures pharmaceutical products are monitored within acceptable temperature ranges during shipping. STEMS provides immediate visibility on upload of shipment temperature reports and allows users to make instant decisions on temperature data essential to management of drug supplies. Providing online data access to sponsors is important to reduce quarantine times in trials where the period from shipment-receipt to dispensation to the patient is limited. This is a key enhancement to Almac’s integrated drug supply management solution that includes Manufacturing & Blinding, Patient Screening and Enrollment, Biostatistical Services, Randomization & Drug Assignment, Packaging and Labeling, Global Distribution & Depot Network, QP Release & Analytical Support, Cold Chain Storage and Shipping Temperature Electronic Monitoring System (STEMS), Drug Inventory Management, Patient Compliance programs, Study Closeout/Drug Reconciliation, IXRS® Technology (IVR/IWR),  and Data Integration & Reporting.

Robert Dunlop, President of Almac’s Clinical Services business unit comments on the significance of this new service offering. “STEMS satisfies an important need of our clients: making certain that drugs used in clinical trials are closely monitored for temperature excursions. By facilitating data upload and removing the need to return temperature control monitors, STEMS significantly streamlines the clinical supplies logistics process. And as part of Almac’s ongoing strategy to improve clinical supply chain management, we are pleased to announce that STEMS is compatible with Sensitech TempTale 4® devices, allowing integration with one of the leading, industry standard monitors.”

Almac will also feature new enhancements to its Patient Compliance service offering at the DIA Conference. As part of its effort to improve patient compliance from initial recruitment to study closeout, Almac will showcase new components of its service offerings: Consulting on Packaging and Label Design for trial supplies and patient reminder services. The latter involves sending patients electronic reminders for a variety of tasks during a clinical trial, such as attending site visits, taking medication, fasting before laboratory visits, and completing Electronic Patient Reported Outcomes (ePRO) diaries, among others.

Almac’s President of Clinical Technologies, Jim Murphy, comments on the enhancements to Almac’s integrated services on patient compliance. “Almac is unique in the industry because we offer services that focus on driving patient compliance throughout the patient’s journey in a clinical trial. Our multi-modal patient reminder services (SMS/text, email and outbound calls) as well as Almac’s expertise in consulting and delivering supplies packaging and labeling services, provide sponsors with a variety of options to improve compliance rates and assure patients adhere to study protocols. Compliance is crucial to assuring patient safety and data quality during the trial, and Almac is focused on helping our clients achieve those key objectives.”

To reinforce its focus on patient management and integrated services, Almac’s industry experts Graham Nicholls, Director of Biostatistics, Hannah O’Gorman, Product Manager of ePRO, and Jennifer Ross, Senior Biostatistician will speak at the DIA conference on topics relating to ePRO, as well as patient retention and compliance in clinical trials.

Please visit booth # 1711 to view demos of STEMS and Almac’s new Patient Compliance Solutions.



Kristi Bronico

T: (1) 215-660-8500

E: [email protected]


About Almac Group

The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 3,000 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has now moved into its new North American Headquarters located in Souderton PA.

For more information about the Almac Group, please visit or e-mail [email protected]


Back to news